Baxter, a United States-headquartered pharmaceutical giant, will invest around Rs 100 crore to set up its global research and development (R&D) headquarters in Ahmedabad, a senior state government official said. “Baxter, one of the largest pharmaceutical companies with a turnover…
CureVac begins Phase III trial of Covid-19 vaccine candidate
Clinical-stage biopharma company CureVac has announced the initiation of Phase III clinical study of its Covid-19 vaccine, CVnCoV, in healthcare workers at the University Medical Center Mainz, Germany. Clinical-stage biopharma company CureVac has announced the initiation of Phase III clinical…
Boehringer initiates trial of novel SARS-CoV-2 neutralising antibody
Boehringer Ingelheim, Cologne University Hospital (UKK), University of Marburg (UMR) and the German Center for Infection Research (DZIF) have initiated Phase I/IIa clinical investigation of novel SARS-CoV-2 neutralising antibody, BI 767551. Boehringer Ingelheim, Cologne University Hospital (UKK), University of Marburg…
EMA Server Breached, Hackers Steal Pfizer/BioNTech Vaccine Data
LONDON (Reuters) – U.S. drugmaker Pfizer and its German partner BioNTech said on Wednesday that documents related to development of their COVID-19 vaccine had been “unlawfully accessed” in a cyberattack on Europe’s medicines regulator. The European Medicines Agency (EMA), which…
Vicore Pharma’s oral C21 provides clinical improvement in Covid-19 trial
GOTHENBURG, Sweden, Dec. 8, 2020 /PRNewswire/ — Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders, today announces positive top line data from the ATTRACT COVID-19 trial with C21 (VP01). A webcast…
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
Pune-based Gennova Biopharmaceuticals Ltd has got conditional permission for phases 1 and 2 human clinical trial of its COVID-19 vaccine. The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial…
Four trial volunteers who got Pfizer’s COVID-19 vaccine developed Bell’s palsy
As the United Kingdom began administering people with the Pfizer-BioNTech vaccine, four people who got Pfizer’s coronavirus vaccine in the firm’s trial developed Bell’s palsy, a form of temporary facial paralysis, according to US regulators’ report on the shot. Food…
Enlivex reports positive interim data from Covid-19 therapy trial
Clinical-stage immunotherapy company Enlivex Therapeutics has reported positive interim data from the Phase II clinical trial of Allocetra in severe and critical Covid-19 patients. Clinical-stage immunotherapy company Enlivex Therapeutics has reported positive interim data from the Phase II clinical trial…
PureTech begins trial of oral molecule for Long COVID respiratory issues
Clinical-stage biotherapeutics company PureTech Health has initiated the global, Phase II trial of LYT-100 (deupirfenidone) in Long COVID respiratory complications and related Sequelae. Clinical-stage biotherapeutics company PureTech Health has initiated the global, Phase II trial of LYT-100 (deupirfenidone) in Long…
Senhwa Biosciences enrols first patient in Covid-19 investigational drug trial
Clinical-stage biopharma firm Senhwa Biosciences has enrolled the first patient in a Phase II investigator-initiated trial (IIT) of its anti-SARS-CoV-2 investigational drug, Silmitasertib, for treating Covid-19. Clinical-stage biopharma firm Senhwa Biosciences has enrolled the first patient in a Phase II…
